A new study at ULiège and a call to established entrepreneurs and young entrepreneurs in student incubators
Prof. David Lyden (Weill Cornell Medical College) inaugurated at ULiège the series of lectures and meetings in Belgium on The pre-metastatic nice concept.
The laboratory of Grégory Ehx and his Canadian colleagues discover that azacitidine, a drug used against leukemia, should be combined with autophagy inhibitors to unleash its full potential.
He receives the award for a research project investigating the molecular mechanisms that shape the genome architecture in Ewing's sarcoma, a pediatric cancer.
3 ULiège research centers with different areas of expertise - GIGA (biology - D. Mottet), CIRM (pharmacy - G. Piel) and CERM (chemistry - A. Debuigne) - have successfully joined forces to carry out this multidisciplinary research project.
The project set up by ULiège researchers aims at a better understanding of the impact of the neuroinflammation process on the neuropathology of the disease and the associated cognitive changes.
ULiège and the CHU of Liège are jointly conducting the ENSEMBLE project, the aim of which is to improve polygenic risk scores in the Walloon population by recruiting 10,000 patients.
Julie Bakker, Charlotte Cornil and Anne-Simone Parent are involved in the European H2020 project "MERLON", which has just been launched in Copenhagen. They will be studying the effects of endocrine disruptors on brain development.
Lijing Tang and colleagues (GIGA Institute – Unit of Animal Genomics) have published a study in Nature Communications refining how the cycle of endogenous retroviruses works in cattle.
Coordinated by the University of Liège, this four-year project brings together sixteen European partners from the healthcare field.
This discovery by researchers from the GIGA - Center of Research Cyclotron at ULiège reveals that the sleeping body also reacts to the external world during sleep, explaining how some information from the sensory environment can affect sleep quality.
Christine Bastin (FNRS, ULiège) has been awarded a 300,000 euros grant by Stop Alzheimer to help detect the first signs of Alzheimer's disease earlier, so that we can benefit from the effectiveness of current treatments.
